Literature DB >> 27683095

Human transcription factors in yeast: the fruitful examples of P53 and NF-кB.

Vasundhara Sharma1, Paola Monti2, Gilberto Fronza3, Alberto Inga1.   

Abstract

The observation that human transcription factors (TFs) can function when expressed in yeast cells has stimulated the development of various functional assays to investigate (i) the role of binding site sequences (herein referred to as response elements, REs) in transactivation specificity, (ii) the impact of polymorphic nucleotide variants on transactivation potential, (iii) the functional consequences of mutations in TFs and (iv) the impact of cofactors or small molecules. These approaches have found applications in basic as well as applied research, including the identification and the characterisation of mutant TF alleles from clinical samples. The ease of genome editing of yeast cells and the availability of regulated systems for ectopic protein expression enabled the development of quantitative reporter systems, integrated at a chosen chromosomal locus in isogenic yeast strains that differ only at the level of a specific RE targeted by a TF or for the expression of distinct TF alleles. In many cases, these assays were proven predictive of results in higher eukaryotes. The potential to work in small volume formats and the availability of yeast strains with modified chemical uptake have enhanced the scalability of these approaches. Next to well-established one-, two-, three-hybrid assays, the functional assays with non-chimeric human TFs enrich the palette of opportunities for functional characterisation. We review ∼25 years of research on human sequence-specific TFs expressed in yeast, with an emphasis on the P53 and NF-кB family of proteins, highlighting outcomes, advantages, challenges and limitations of these heterologous assays. © FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NF-kB; Saccharomyces cerevisiae; functional assay; nuclear receptors; p53; p63; p73

Mesh:

Substances:

Year:  2016        PMID: 27683095     DOI: 10.1093/femsyr/fow083

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  5 in total

1.  The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms.

Authors:  Otília Porubiaková; Natália Bohálová; Alberto Inga; Natália Vadovičová; Jan Coufal; Miroslav Fojta; Václav Brázda
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

2.  Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.

Authors:  Paola Monti; Vaclav Brazda; Natália Bohálová; Otília Porubiaková; Paola Menichini; Andrea Speciale; Renata Bocciardi; Alberto Inga; Gilberto Fronza
Journal:  Genes (Basel)       Date:  2021-02-15       Impact factor: 4.096

3.  Selective functional inhibition of a tumor-derived p53 mutant by cytosolic chaperones identified using split-YFP in budding yeast.

Authors:  Ashley S Denney; Andrew D Weems; Michael A McMurray
Journal:  G3 (Bethesda)       Date:  2021-09-06       Impact factor: 3.154

4.  A Protein in the Yeast Saccharomyces cerevisiae Presents DNA Binding Homology to the p53 Checkpoint Protein and Tumor Suppressor.

Authors:  Kanwal Farooqi; Marjan Ghazvini; Leah D Pride; Louis Mazzella; David White; Ajay Pramanik; Jill Bargonetti; Carol Wood Moore
Journal:  Biomolecules       Date:  2020-03-07

5.  P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development.

Authors:  Paola Monti; Yari Ciribilli; Giorgia Foggetti; Paola Menichini; Alessandra Bisio; Serena Cappato; Alberto Inga; Maria Teresa Divizia; Margherita Lerone; Renata Bocciardi; Gilberto Fronza
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.